These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 25701462)
21. Retraction note to: decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer. Med Oncol; 2015 Oct; 32(10):243. PubMed ID: 26395200 [TBL] [Abstract][Full Text] [Related]
22. Active post-transcriptional regulation and ACLY-mediated acetyl-CoA synthesis as a pivotal target of Shuang-Huang-Sheng-Bai formula for lung adenocarcinoma treatment. Liu D; Dong C; Wang F; Liu W; Jin X; Qi SL; Liu L; Jin Q; Wang S; Wu J; Wang C; Yang J; Deng H; Cai Y; Yang L; Qin J; Zhang C; Yang X; Wang MS; Yu G; Xue YW; Wang Z; Ge GB; Xu Z; Chen WL Phytomedicine; 2023 May; 113():154732. PubMed ID: 36933457 [TBL] [Abstract][Full Text] [Related]
24. ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury. Li R; Meng M; Chen Y; Pan T; Li Y; Deng Y; Zhang R; Tian R; Xu W; Zheng X; Gong F; Liu J; Tang H; Ding X; Tang Y; Annane D; Chen E; Qu H; Li L Cell Death Dis; 2023 Jul; 14(7):401. PubMed ID: 37414769 [TBL] [Abstract][Full Text] [Related]
25. An allosteric mechanism for potent inhibition of human ATP-citrate lyase. Wei J; Leit S; Kuai J; Therrien E; Rafi S; Harwood HJ; DeLaBarre B; Tong L Nature; 2019 Apr; 568(7753):566-570. PubMed ID: 30944472 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells Teng L; Chen Y; Cao Y; Wang W; Xu Y; Wang Y; Lv J; Li C; Su Y Oncol Lett; 2018 May; 15(5):6967-6974. PubMed ID: 29725424 [TBL] [Abstract][Full Text] [Related]
27. Targeting mitochondrial citrate transport in breast cancer cell lines. Ozkaya AB; Ak H; Atay S; Aydin HH Anticancer Agents Med Chem; 2015; 15(3):374-81. PubMed ID: 25511512 [TBL] [Abstract][Full Text] [Related]
28. Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer. Bian Y; Yu Y; Wang S; Li L Biochem Biophys Res Commun; 2015 Aug; 463(4):612-7. PubMed ID: 26043686 [TBL] [Abstract][Full Text] [Related]
29. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172 [TBL] [Abstract][Full Text] [Related]
30. High-Throughput Single-Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma. Liu Q; Ge W; Wang T; Lan J; Martínez-Jarquín S; Wolfrum C; Stoffel M; Zenobi R Angew Chem Int Ed Engl; 2021 Nov; 60(46):24534-24542. PubMed ID: 34505339 [TBL] [Abstract][Full Text] [Related]
31. Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia. Xie Z; Zhang M; Song Q; Cheng L; Zhang X; Song G; Sun X; Gu M; Zhou C; Zhang Y; Zhu K; Yin J; Chen X; Li J; Nan F Acta Pharm Sin B; 2023 Feb; 13(2):739-753. PubMed ID: 36873173 [TBL] [Abstract][Full Text] [Related]
32. Discovery of a new ATP-citrate lyase (ACLY) inhibitor identified by a pharmacophore-based virtual screening study. Jha V; Galati S; Volpi V; Ciccone L; Minutolo F; Rizzolio F; Granchi C; Poli G; Tuccinardi T J Biomol Struct Dyn; 2021 Jul; 39(11):3996-4004. PubMed ID: 32448086 [TBL] [Abstract][Full Text] [Related]
33. Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase. Ismail A; Mokhlis HA; Sharaky M; Sobhy MH; Hassanein SS; Doghish AS; Salama SA; Mariee AD; Attia YM Pathol Res Pract; 2022 Dec; 240():154211. PubMed ID: 36401980 [TBL] [Abstract][Full Text] [Related]
34. ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate. Keenan MM; Liu B; Tang X; Wu J; Cyr D; Stevens RD; Ilkayeva O; Huang Z; Tollini LA; Murphy SK; Lucas J; Muoio DM; Kim SY; Chi JT PLoS Genet; 2015 Oct; 11(10):e1005599. PubMed ID: 26452058 [TBL] [Abstract][Full Text] [Related]
35. ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective. Granchi C Expert Opin Ther Pat; 2022 Jul; 32(7):731-742. PubMed ID: 35436171 [TBL] [Abstract][Full Text] [Related]
36. ACLY is the novel signaling target of PIP Basappa J; Citir M; Zhang Q; Wang HY; Liu X; Melnikov O; Yahya H; Stein F; Muller R; Traynor-Kaplan A; Schultz C; Wasik MA; Ptasznik A Heliyon; 2020 May; 6(5):e03910. PubMed ID: 32420483 [TBL] [Abstract][Full Text] [Related]
37. Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth. Gao Y; Islam MS; Tian J; Lui VW; Xiao D Cancer Lett; 2014 Jul; 349(1):15-25. PubMed ID: 24690568 [TBL] [Abstract][Full Text] [Related]
38. ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis. Wang D; Yin L; Wei J; Yang Z; Jiang G Tumour Biol; 2017 Apr; 39(4):1010428317698338. PubMed ID: 28443474 [TBL] [Abstract][Full Text] [Related]
39. ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ-proteasome pathway. Cai Q; Zhu H; Dai Y; Zhou Q; Zhang Q; Zhu Q Mol Carcinog; 2024 Oct; 63(10):1874-1891. PubMed ID: 38888205 [TBL] [Abstract][Full Text] [Related]
40. Identification of the active site residues in ATP-citrate lyase's carboxy-terminal portion. Nguyen VH; Singh N; Medina A; Usón I; Fraser ME Protein Sci; 2019 Oct; 28(10):1840-1849. PubMed ID: 31411782 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]